Greenwood Corryn, Morrow Ardythe L, Lagomarcino Anne J, Altaye Mekibib, Taft Diana H, Yu Zhuoteng, Newburg David S, Ward Doyle V, Schibler Kurt R
Perinatal Institute, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; Division of Neonatology, Advocate Children's Hospital, Oak Lawn, IL.
Perinatal Institute, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH; Division of Biostatistics and Epidemiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH.
J Pediatr. 2014 Jul;165(1):23-9. doi: 10.1016/j.jpeds.2014.01.010. Epub 2014 Feb 13.
To determine the impact of empiric ampicillin and gentamicin use in the first week of life on microbial colonization and diversity in preterm infants.
The 16s ribosomal DNA community profiling was used to compare the microbiota of 74 infants born ≤32 weeks gestational age by degree of antibiotic use in the first week of life. The degree of antibiotic use was classified as 0 days, 1-4 days, and 5-7 days of antibiotic administration. All of the antibiotic use was empiric, defined as treatment based solely on clinical suspicion of infection without a positive culture result.
Infants who received 5-7 days of empiric antimicrobial agents in the first week had increased relative abundance of Enterobacter (P = .016) and lower bacterial diversity in the second and third weeks of life. Infants receiving early antibiotics also experienced more cases of necrotizing enterocolitis, sepsis, or death than those not exposed to antibiotics.
Early empiric antibiotics have sustained effects on the intestinal microbiota of preterm infants. Intestinal dysbiosis in this population has been found to be associated with elevated risk of necrotizing enterocolitis, sepsis, or death.
确定出生后第一周经验性使用氨苄西林和庆大霉素对早产儿微生物定植及多样性的影响。
采用16s核糖体DNA群落分析方法,根据出生后第一周抗生素使用程度,比较74例胎龄≤32周的婴儿的微生物群。抗生素使用程度分为使用抗生素0天、1 - 4天和5 - 7天。所有抗生素使用均为经验性用药,即仅基于临床感染怀疑而无阳性培养结果进行的治疗。
在出生后第一周接受5 - 7天经验性抗菌药物治疗的婴儿,在出生后第二周和第三周,肠杆菌相对丰度增加(P = .016),细菌多样性降低。接受早期抗生素治疗的婴儿比未接触抗生素的婴儿发生坏死性小肠结肠炎、败血症或死亡的病例更多。
早期经验性使用抗生素对早产儿肠道微生物群有持续影响。已发现该人群肠道菌群失调与坏死性小肠结肠炎、败血症或死亡风险升高有关。